256 related articles for article (PubMed ID: 26974655)
21. ToP-DNJ, a Selective Inhibitor of Endoplasmic Reticulum α-Glucosidase II Exhibiting Antiflaviviral Activity.
Kiappes JL; Hill ML; Alonzi DS; Miller JL; Iwaki R; Sayce AC; Caputo AT; Kato A; Zitzmann N
ACS Chem Biol; 2018 Jan; 13(1):60-65. PubMed ID: 29161006
[TBL] [Abstract][Full Text] [Related]
22. Targeting Endoplasmic Reticulum α-Glucosidase I with a Single-Dose Iminosugar Treatment Protects against Lethal Influenza and Dengue Virus Infections.
Warfield KL; Alonzi DS; Hill JC; Caputo AT; Roversi P; Kiappes JL; Sheets N; Duchars M; Dwek RA; Biggins J; Barnard D; Shresta S; Treston AM; Zitzmann N
J Med Chem; 2020 Apr; 63(8):4205-4214. PubMed ID: 32227946
[TBL] [Abstract][Full Text] [Related]
23. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses.
Chang J; Warren TK; Zhao X; Gill T; Guo F; Wang L; Comunale MA; Du Y; Alonzi DS; Yu W; Ye H; Liu F; Guo JT; Mehta A; Cuconati A; Butters TD; Bavari S; Xu X; Block TM
Antiviral Res; 2013 Jun; 98(3):432-40. PubMed ID: 23578725
[TBL] [Abstract][Full Text] [Related]
24. Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs.
Block TM; Jordan R
Antivir Chem Chemother; 2001 Nov; 12(6):317-25. PubMed ID: 12018676
[TBL] [Abstract][Full Text] [Related]
25. Polyhydroxylated Quinolizidine Iminosugars as Nanomolar Selective Inhibitors of α-Glucosidases.
Vieira Da Cruz A; Kanazawa A; Poisson JF; Behr JB; Py S
J Org Chem; 2017 Sep; 82(18):9866-9872. PubMed ID: 28752763
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of endoplasmic reticulum alpha-glucosidases potently suppress hepatitis C virus virion assembly and release.
Qu X; Pan X; Weidner J; Yu W; Alonzi D; Xu X; Butters T; Block T; Guo JT; Chang J
Antimicrob Agents Chemother; 2011 Mar; 55(3):1036-44. PubMed ID: 21173177
[TBL] [Abstract][Full Text] [Related]
27. α-Glucosidase-inhibitory iminosugars from the leaves of Suregada glomerulata.
Yan RY; Wang HQ; Liu C; Kang J; Chen RY
Bioorg Med Chem; 2013 Nov; 21(21):6796-803. PubMed ID: 23993676
[TBL] [Abstract][Full Text] [Related]
28. Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals.
Caputo AT; Alonzi DS; Marti L; Reca IB; Kiappes JL; Struwe WB; Cross A; Basu S; Lowe ED; Darlot B; Santino A; Roversi P; Zitzmann N
Proc Natl Acad Sci U S A; 2016 Aug; 113(32):E4630-8. PubMed ID: 27462106
[TBL] [Abstract][Full Text] [Related]
29. Glycomimetics at the mirror: medicinal chemistry of L-iminosugars.
D'Alonzo D; Guaragna A; Palumbo G
Curr Med Chem; 2009; 16(4):473-505. PubMed ID: 19199917
[TBL] [Abstract][Full Text] [Related]
30. Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model.
Rathore AP; Paradkar PN; Watanabe S; Tan KH; Sung C; Connolly JE; Low J; Ooi EE; Vasudevan SG
Antiviral Res; 2011 Dec; 92(3):453-60. PubMed ID: 22020302
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of bicyclic iminosugar hybrids: conformational constraint as an effective tool for tailoring the selectivity of α-glucosidase inhibitors.
Arora I; Kashyap VK; Singh AK; Dasgupta A; Kumar B; Shaw AK
Org Biomol Chem; 2014 Sep; 12(35):6855-68. PubMed ID: 25050482
[TBL] [Abstract][Full Text] [Related]
32. Iminosugar Glucosidase Inhibitors Reduce Hepatic Inflammation in Hepatitis A Virus-Infected
Misumi I; Li Z; Sun L; Das A; Shiota T; Cullen J; Zhang Q; Whitmire JK; Lemon SM
J Virol; 2021 May; 95(11):e0005821. PubMed ID: 33692213
[TBL] [Abstract][Full Text] [Related]
33. Dengue Virus Selectively Annexes Endoplasmic Reticulum-Associated Translation Machinery as a Strategy for Co-opting Host Cell Protein Synthesis.
Reid DW; Campos RK; Child JR; Zheng T; Chan KWK; Bradrick SS; Vasudevan SG; Garcia-Blanco MA; Nicchitta CV
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321322
[TBL] [Abstract][Full Text] [Related]
34. Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors.
Kato A; Hirokami Y; Kinami K; Tsuji Y; Miyawaki S; Adachi I; Hollinshead J; Nash RJ; Kiappes JL; Zitzmann N; Cha JK; Molyneux RJ; Fleet GW; Asano N
Phytochemistry; 2015 Mar; 111():124-31. PubMed ID: 25583438
[TBL] [Abstract][Full Text] [Related]
35. Structural basis of the inhibition of GH1 β-glucosidases by multivalent pyrrolidine iminosugars.
Martínez-Bailén M; Jiménez-Ortega E; Carmona AT; Robina I; Sanz-Aparicio J; Talens-Perales D; Polaina J; Matassini C; Cardona F; Moreno-Vargas AJ
Bioorg Chem; 2019 Aug; 89():103026. PubMed ID: 31226649
[TBL] [Abstract][Full Text] [Related]
36. Structural Insights into the Broad-Spectrum Antiviral Target Endoplasmic Reticulum Alpha-Glucosidase II.
Caputo AT; Alonzi DS; Kiappes JL; Struwe WB; Cross A; Basu S; Darlot B; Roversi P; Zitzmann N
Adv Exp Med Biol; 2018; 1062():265-276. PubMed ID: 29845539
[TBL] [Abstract][Full Text] [Related]
37. Design and Synthesis of Labystegines, Hybrid Iminosugars from LAB and Calystegine, as Inhibitors of Intestinal α-Glucosidases: Binding Conformation and Interaction for ntSI.
Kato A; Zhang ZL; Wang HY; Jia YM; Yu CY; Kinami K; Hirokami Y; Tsuji Y; Adachi I; Nash RJ; Fleet GW; Koseki J; Nakagome I; Hirono S
J Org Chem; 2015 May; 80(9):4501-15. PubMed ID: 25843107
[TBL] [Abstract][Full Text] [Related]
38. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
[TBL] [Abstract][Full Text] [Related]
39. Structure-Based Design of Potent Iminosugar Inhibitors of Endoplasmic Reticulum α-Glucosidase I with Anti-SARS-CoV-2 Activity.
Karade SS; Franco EJ; Rojas AC; Hanrahan KC; Kolesnikov A; Yu W; MacKerell AD; Hill DC; Weber DJ; Brown AN; Treston AM; Mariuzza RA
J Med Chem; 2023 Feb; 66(4):2744-2760. PubMed ID: 36762932
[TBL] [Abstract][Full Text] [Related]
40. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.
Ma J; Zhang X; Soloveva V; Warren T; Guo F; Wu S; Lu H; Guo J; Su Q; Shen H; Solon E; Comunale MA; Mehta A; Guo JT; Bavari S; Du Y; Block TM; Chang J
Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
